Product correctly added to cart.

N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

CAS 391210-10-9: N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

Description:N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide, with CAS number 391210-10-9, is a synthetic organic compound characterized by its complex molecular structure, which includes multiple functional groups such as amides, fluorine, and iodine substituents. This compound features a benzamide core, which is modified by the presence of difluoro and iodo groups, contributing to its potential biological activity. The dihydroxypropoxy moiety suggests that it may exhibit hydrophilic properties, enhancing its solubility in polar solvents. The presence of halogens, particularly fluorine and iodine, often influences the compound's reactivity and pharmacokinetic properties, making it of interest in medicinal chemistry. Such compounds are typically investigated for their potential therapeutic applications, including anti-cancer or anti-inflammatory activities. Additionally, the stereochemistry indicated by the (2R) configuration may play a crucial role in the compound's biological interactions and efficacy. Overall, this compound exemplifies the intricate design often found in drug development, where specific substitutions are made to optimize desired properties.

Formula:C16H14F3IN2O4

InChI:InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1

InChI key:InChIKey=SUDAHWBOROXANE-SECBINFHSA-N

SMILES:O=C(NOCC(O)CO)C1=CC=C(F)C(F)=C1NC2=CC=C(I)C=C2F

  • Synonyms:
  • Benzamide, N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-
  • Mirdametinib
  • N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
  • N-[((R)-2,3-Dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
  • N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide
  • N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
  • Pd 0325901
  • Pd 03525901
  • Pd 325901
  • Pd 901
  • See more synonyms
  • Pd325901
Sort by


See more categories

This search does not contain any category.

Found 9 products.

discount label

N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

CAS:391210-10-9

Ref: IN-DA0037IF

1g583.00 €
5gTo inquire
5mg52.00 €
100mg198.00 €
250mg240.00 €
Estimated delivery in United States, on Thursday 17 Apr 2025
discount label

Mirdametinib

CAS:391210-10-9

Ref: 54-BUP15010

1g1,216.00 €
50mg273.00 €
100mg414.00 €
200mg607.00 €
500mg971.00 €
Estimated delivery in United States, on Monday 21 Apr 2025
discount label

PD 0325901

CAS:391210-10-9

Ref: 3B-P2897

10mg123.00 €
Estimated delivery in United States, on Tuesday 22 Apr 2025
discount label

PD 0325901

CAS:391210-10-9

Ref: 7W-GL5463

1mg86.00 €
5mg123.00 €
25mg281.00 €
Estimated delivery in United States, on Thursday 24 Apr 2025
discount label

Mirdametinib

CAS:391210-10-9

Ref: TM-T6189

1g898.00 €
5mg51.00 €
10mg74.00 €
25mg127.00 €
50mg175.00 €
100mg273.00 €
200mg406.00 €
500mg662.00 €
1mL*10mM (DMSO)55.00 €
Estimated delivery in United States, on Thursday 24 Apr 2025
discount label

PD0325901

CAS:391210-10-9

Ref: 54-BISN0215

5mg191.00 €
10mg323.00 €
25mg571.00 €
Estimated delivery in United States, on Thursday 24 Apr 2025
discount label

Ref: 4Z-PF-0003

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Thursday 24 Apr 2025
discount label

PD 0325901

CAS:391210-10-9

Ref: 3D-FP26781

10mg147.00 €
25mg208.00 €
50mg255.00 €
100mg360.00 €
250mg532.00 €
Estimated delivery in United States, on Monday 28 Apr 2025
discount label

rac-PD-325901-d5

Controlled Product
CAS:391210-10-9

Ref: TR-P217452

25mg3,864.00 €
Estimated delivery in United States, on Wednesday 28 May 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".